News

Welcome to the sixth issue of our report, “Mpox: Transparency and Accountability for the Global Response.” In this edition, we provide a comprehensive update on the latest developments and insights across all topic areas, featuring our most recent analyses and findings since the last issue. This report will be updated and shared every other week with our community. Latest updates at a glance: The first patients have been enrolled in the MOSA trial in the DRC. This trial will evaluate different antivirals, starting with evaluating the safety and efficacy of brincidofovir (Emergent BioSolutions). Sierra Leone has reported its first 2 mpox cases in the country, and becomes the 21st country in Africa to report a case of mpox. The U.S. CDC has donated 300 mpox tests to Sierra Leone to help…

Welcome to the fifth issue of our report, “Mpox: Transparency and Accountability for the Global Response.” In this edition, we provide a comprehensive update on the latest developments and insights across all topic areas, featuring our most recent analyses and findings since the last issue. This report will be updated and shared every other week with our community. As always, we aim to serve as an external, independent source for tracking and catalyzing effective actions to meet and increase commitments, and to hold the key stakeholders to account for achieving emergency preparedness and response goals. Access the full report.

Welcome to the fourth issue of our biweekly report, “Mpox: Transparency and Accountability for the Global Response.” In this edition, we provide a comprehensive update on the latest developments and insights across all topic areas, featuring our most recent analyses and findings since the last issue. This report will be updated and shared every other week with our community. As always, we aim to serve as an external, independent source for tracking and catalyzing effective actions to meet and increase commitments, and to hold the key stakeholders to account for achieving emergency preparedness and response goals. Access the full report.

Welcome to the third issue of our biweekly report, “Mpox: Transparency and Accountability for the Global Response.” In this edition, we provide a comprehensive update on the latest developments and insights across all topic areas, featuring our most recent analyses and findings since the last issue. This report will be updated and shared every other week with our community. As always, we aim to serve as an external, independent source for tracking and catalyzing effective actions to meet and increase commitments, and to hold the key stakeholders to account for achieving emergency preparedness and response goals. Access the full report.